Cita APA (7th ed.)

Jadersten, M., Pellagatti, A., Forsblom, A., Emanuelsson, E., Merup, M., Samuelsson, J., . . . Hellstorm-Lindberg, E. (2005). Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.

Cita Chicago (17th ed.)

Jadersten, M., A. Pellagatti, A. Forsblom, E. Emanuelsson, M. Merup, J. Samuelsson, J. Wainscoat, J. Boultwood, i E. Hellstorm-Lindberg. Lenalidomide Selectively Inhibits in Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome (MDS) Patients with 5q Deletion. 2005.

Cita MLA (9th ed.)

Jadersten, M., et al. Lenalidomide Selectively Inhibits in Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome (MDS) Patients with 5q Deletion. 2005.